Clinical Outcomes of Coronary Revascularization without Cardiopulmonary Bypass
Objective: Coronary artery bypass without cardiopulmonary bypass (OPCAB) eliminates the complications related to cardiopulmonary bypass. However, the long-term outcomes of this procedure are largely unknown.
Methods: We sought to investigate the rates of late mortality, stroke, acute myocardial infarction, and target vessel reintervention after OPCAB in a consecutive series of 857 patients who underwent OPCAB between May 1987 and March 1999.
Results: Long-term follow-up was obtained for 86% of eligible patients. Actuarial and event-free survival was 89% and 76%, respectively, for a median follow-up period of 2.2 years (range, 0-13.3 years). Risk factors for late mortality were identified with Cox regression analysis. In the multivariate analysis, patient age >75 years (odds ratio, 1.1; 95% confidence interval, 1.0-1.1; P = .01) and an ejection fraction <35% (odds ratio, 2.7; 95% confidence interval, 1.2-6.2; P = .02) emerged as independent predictors of late mortality.
Conclusion: OPCAB is associated with a low mortality and clinical event rate. Advanced age and depressed ejection fraction may increase mortality after OPCAB.
Allen KB, Matheny RG, Robinson RJ, Heimansohn DA, Shaar CJ. 1997. Minimally invasive versus conventional reoperative coronary artery bypass. Ann Thorac Surg 64:616-22.nBerger PB, Alderman EL, Nadel A, Schaff HV. 1999. Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass. Circulation 100:2353-8.nBhaskerRao B, VanHimbergen D, Edmonds HL Jr, et al. 1998. Evidence for improved cerebral function after minimally invasive bypass surgery. J Card Surg 13:27-31.nCernaianu AC, Vassilidze TV, Flum DR, et al. 1995. Predictors of stroke after cardiac surgery. J Card Surg 10:334-9.nFitzGibbon GM, Burton JR, Leach AJ. 1978. Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year. Circulation 57:1070-4.nGundry SR, Romano MA, Shattuck OH, Razzouk AJ, Bailey LL. 1998. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg 115:1273-8.nHerlitz J, Brandrup-Wognsen G, Karlson BW, et al. 2000. Mortality, risk indicators for death, and mode of death in younger and elderly patients during five years after coronary artery bypass graft. Clin Cardiol 23:421-6.nLancey RA, Babs RS, Vander Salm TJ. 2001. Off-pump versus on-pump coronary artery bypass surgery: a case-matched comparison of clinical outcomes and costs. Heart Surg Forum 3:277-81.nLytle BW. 1996. Minimally invasive cardiac surgery. J Thorac Cardiovasc Surg 111:554-5.nMagee MJ, Jablonski KA, Stamou SC, et al. 2002. Elimination of cardiopulmonary bypass improves early survival in multivessel coronary artery bypass patients. Ann Thorac Surg 73:1196-203.nMehran R, Dangas G, Stamou SC, et al. 2000. One year clinical outcome after minimally invasive direct coronary artery bypass. Circulation 102:2799-802.nPuskas JD, Wright CE, Ronson RS, Brown WM 3rd, Gott JP, Guyton RA. 1998. Off-pump multivessel coronary bypass via sternotomy is safe and effective. Ann Thorac Surg 66:1068-72.nStamou SC, Corso PJ. 2001. Coronary revascularization in high-risk patients: a route to the future. Ann Thorac Surg 71:1056-61.nStamou SC, Pfister AJ, Dangas G, et al. 2000. Beating heart versus conventional single vessel reoperative coronary artery bypass surgery. Ann Thorac Surg 69:1383-7.nStanbridge RD, Hadjinikolaou LK, Cohen AS, Foale RA, Davies WD, Kutoubi AA. 1997. Minimally invasive coronary revascularization through parasternal incisions without cardiopulmonary bypass. Ann Thorac Surg 63:S53-6.nSubramanian V. 1999. Minimally invasive coronary artery bypass grafting on the beating heart: the American experience. In: Oz MC, Goldstein DJ, editors. Minimally invasive cardiac surgery. Totowa, NJ: Humana Press. p 89-103. Ullyot DJ. 1996. Look ma, no hands! Ann Thorac Surg 61:10-1.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).